Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
Myriad Genetics released results from its GeneSight Mental Health Monitor survey, finding that 88% of patients with depression and/or anxiety would feel more confident with a personalized mental health care plan. The survey of 1,002 U.S. adults indicated that 65% of respondents were unaware genetic testing could inform medication decisions, yet 55% said they would have preferred their provider offer it.
Key figures
- Survey dates
- February 23 — March 6, 2026
- Survey sample size
- 1002
- Survey margin of error
- +/- 4%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.